Clinical Trial Update: A Study of Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Distributed, Metabolized and Eliminated Over a Period of Time) in the Body of Female Patients With Active Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of SCIO-469 in female patients with active rheumatoid arthritis to characterize absorption, distribution, metabolism, and eliminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SCIO-469

Snippet

Sponsor: Scios, Inc. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED